刊名:Journal of Cancer Research and Clinical Oncology
出版年:2017
出版时间:March 2017
年:2017
卷:143
期:3
页码:509-519
全文大小:
刊物类别:Medicine
刊物主题:Oncology; Cancer Research; Internal Medicine; Hematology;
出版者:Springer Berlin Heidelberg
ISSN:1432-1335
卷排序:143
文摘
BackgroundDe novo stage IV breast cancer patients (BCIV) depict a clinical picture not influenced by adjuvant therapy. Therefore, the time-dependent impact of changes in diagnostics and treatments on progression and survival can best be evaluated in this subgroup.